Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Novocure Stock Is Jumping Today

TheMotleyFool 
0 0 28.03.24
Why Novocure Stock Is Jumping Today: https://g.foolcdn.com/editorial/images/770997/novocure-person-with-ttfields-on-head.jpg
 

Shares of (NASDAQ: NVCR) were jumping 6.3% higher as of 11:15 a.m. ET on Thursday after rising as much as 9.2% earlier in the day. The nice gain came after the company announced results from a phase 3 study evaluating its Tumor Treating Fields (TTFields) therapy in treating patients with brain metastases from non-small cell lung cancer (NSCLC).

Novocure reported that patients receiving TTFields therapy in the late-stage study had a median time to intracranial progression of 21.9 months. This result reflected a statistically significant improvement from the 11.3 months for patients treated with only supportive care such as anticoagulants, nausea medications, and steroids. Minesh Mehta, Miami Cancer Institute's chief of radiation oncology and deputy director, said TTFields "is potentially practice changing" in treating brain metastases.

However, the news wasn't all positive for Novocure. The company revealed that preliminary analyses of key secondary endpoints of the study, including overall survival, radiological response rate, and time to neurocognitive failure, weren't achieved. A full analysis of these secondary endpoints is still underway.

Continue reading


Source Fool.com

Novocure Ltd Stock

€15.32
-1.990%
A loss of -1.990% shows a downward development for Novocure Ltd.

Show more
Like: 0
NVCR
Share

Comments

Not a member yet? Sign up for free!